A detailed history of Bank Of Montreal transactions in Haemonetics Corp stock. As of the latest transaction made, Bank Of Montreal holds 7,167 shares of HAE stock, worth $560,172. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,167
Previous 6,817 5.13%
Holding current value
$560,172
Previous $581,000 1.89%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$81.24 - $97.37 $28,434 - $34,079
350 Added 5.13%
7,167 $592,000
Q1 2024

May 13, 2024

SELL
$71.24 - $85.35 $13,464 - $16,131
-189 Reduced 2.7%
6,817 $581,000
Q4 2023

Feb 08, 2024

SELL
$80.59 - $92.61 $32,800 - $37,692
-407 Reduced 5.49%
7,006 $599,000
Q3 2023

Nov 01, 2023

SELL
$82.56 - $93.49 $201,033 - $227,648
-2,435 Reduced 24.73%
7,413 $664,000
Q2 2023

Aug 02, 2023

SELL
$80.84 - $89.45 $401,936 - $444,745
-4,972 Reduced 33.55%
9,848 $838,000
Q1 2023

Jun 13, 2024

BUY
$72.75 - $90.6 $330,794 - $411,958
4,547 Added 66.7%
11,364 $940,000
Q4 2022

Feb 01, 2023

BUY
$73.85 - $86.14 $53,171 - $62,020
720 Added 5.11%
14,820 $1.17 Million
Q3 2022

Nov 10, 2022

SELL
$63.3 - $78.66 $2.06 Million - $2.57 Million
-32,612 Reduced 69.82%
14,100 $1.1 Million
Q2 2022

Aug 11, 2022

BUY
$49.27 - $66.08 $673,668 - $903,511
13,673 Added 41.38%
46,712 $3.06 Million
Q1 2022

May 12, 2022

BUY
$43.77 - $63.22 $1.08 Million - $1.57 Million
24,785 Added 300.28%
33,039 $2.03 Million
Q4 2021

Feb 11, 2022

SELL
$49.55 - $74.59 $1.11 Million - $1.68 Million
-22,487 Reduced 73.15%
8,254 $446,000
Q3 2021

Nov 12, 2021

SELL
$57.6 - $70.59 $4.61 Million - $5.65 Million
-80,035 Reduced 72.25%
30,741 $2.18 Million
Q2 2021

Aug 12, 2021

BUY
$51.81 - $118.56 $5.74 Million - $13.1 Million
110,776 New
110,776 $7.49 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.01B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.